Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.
Key Features:
-Overcomes the blood-brain barrier using advanced delivery methods.
-Improves drug penetration & specificity with nano and polymer-based systems.
-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.
-Builds preclinical models & identifies biomarkers to support clinical success.
-Designs regulatory-aligned clinical trial strategies for faster translation.